| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
180,310,000 |
| Market
Cap: |
41.24(B) |
| Last
Volume: |
799,597 |
Avg
Vol: |
864,930 |
| 52
Week Range: |
$191.51 - $228.9 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Seagen is a biotechnology company that develops and commercializes targeted therapies to treat cancer. Co. is commercializing ADCETRIS®, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas, PADCEV®, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, TIVDAK™, or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers, and TUKYSA®, or tucatinib, for treatment of certain metastatic HER2-positive breast cancers. Co. is also developing a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
39,326 |
449,967 |
| Total Sell Value |
$0 |
$0 |
$8,245,949 |
$81,866,696 |
| Total People Sold |
0 |
0 |
7 |
8 |
| Total Sell Transactions |
0 |
0 |
18 |
69 |
| End Date |
2024-03-31 |
2023-12-29 |
2023-06-30 |
2022-06-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Baker Felix |
Director |
– • • |
2008-02-08 |
4 |
B |
$8.94 |
$25,672 |
I/I |
2,852 |
146,270 |
2.25 |
- |
|
| Baker Felix |
Director |
– • • |
2008-02-08 |
4 |
B |
$8.94 |
$182,205 |
I/I |
20,242 |
3,859,485 |
2.25 |
- |
|
| Baker Felix |
Director |
– • • |
2008-02-07 |
4 |
B |
$9.00 |
$873 |
I/I |
97 |
363,765 |
2.17 |
- |
|
| Baker Felix |
Director |
– • • |
2008-02-07 |
4 |
B |
$9.00 |
$630 |
I/I |
70 |
476,243 |
2.17 |
- |
|
| Baker Felix |
Director |
– • • |
2008-02-07 |
4 |
B |
$9.00 |
$231,681 |
I/I |
25,744 |
7,512,744 |
2.25 |
- |
|
| Baker Felix |
Director |
– • • |
2008-02-07 |
4 |
B |
$9.00 |
$7,371 |
I/I |
819 |
143,418 |
2.17 |
- |
|
| Baker Felix |
Director |
– • • |
2008-02-07 |
4 |
B |
$9.00 |
$52,287 |
I/I |
5,810 |
3,839,243 |
2.25 |
- |
|
| Baker Felix |
Director |
– • • |
2008-01-23 |
4 |
B |
$9.03 |
$2,338 |
I/I |
259 |
476,173 |
2.17 |
- |
|
| Baker Felix |
Director |
– • • |
2008-01-23 |
4 |
B |
$9.03 |
$17,288 |
I/I |
1,915 |
363,668 |
2.17 |
- |
|
| Baker Felix |
Director |
– • • |
2008-01-23 |
4 |
B |
$9.03 |
$864,105 |
I/I |
95,716 |
7,487,000 |
2.25 |
- |
|
| Baker Felix |
Director |
– • • |
2008-01-23 |
4 |
B |
$9.03 |
$27,490 |
I/I |
3,045 |
142,599 |
2.25 |
- |
|
| Berger Franklin M |
Director |
– • – |
2008-01-22 |
4 |
B |
$9.12 |
$4,815 |
D/D |
528 |
72,220 |
2.31 |
- |
|
| Baker Felix |
Director |
– • • |
2008-01-22 |
4 |
B |
$8.78 |
$1,404 |
I/I |
160 |
475,914 |
2.17 |
- |
|
| Baker Felix |
Director |
– • • |
2008-01-22 |
4 |
B |
$8.78 |
$11,797 |
I/I |
1,344 |
361,753 |
2.17 |
- |
|
| Baker Felix |
Director |
– • • |
2008-01-22 |
4 |
B |
$8.78 |
$165,623 |
I/I |
18,869 |
3,833,433 |
2.25 |
- |
|
| Baker Felix |
Director |
– • • |
2008-01-22 |
4 |
B |
$8.78 |
$571,758 |
I/I |
65,139 |
7,391,284 |
2.25 |
- |
|
| Baker Felix |
Director |
– • • |
2008-01-22 |
4 |
B |
$8.78 |
$18,292 |
I/I |
2,084 |
139,554 |
2.17 |
- |
|
| Baker Felix |
Director |
– • • |
2008-01-18 |
4 |
B |
$9.00 |
$42,723 |
I/I |
4,747 |
475,754 |
2.25 |
- |
|
| Baker Felix |
Director |
– • • |
2008-01-18 |
4 |
B |
$9.00 |
$359,199 |
I/I |
39,911 |
360,409 |
2.25 |
- |
|
| Baker Felix |
Director |
– • • |
2008-01-18 |
4 |
B |
$9.00 |
$5,040,423 |
I/I |
560,047 |
3,814,564 |
2.25 |
- |
|
| Baker Felix |
Director |
– • • |
2008-01-18 |
4 |
B |
$9.00 |
$17,400,807 |
I/I |
1,933,423 |
7,326,145 |
2.25 |
- |
|
| Baker Felix |
Director |
– • • |
2008-01-18 |
4 |
B |
$9.00 |
$556,848 |
I/I |
61,872 |
137,470 |
2.25 |
- |
|
| Gryska David W |
Director |
– • – |
2008-01-17 |
4 |
OE |
$4.18 |
$25,080 |
D/D |
6,000 |
13,500 |
|
- |
|
| Dobmeier Eric |
Chief Business Officer |
• – – |
2007-12-20 |
4 |
OE |
$5.25 |
$26,250 |
D/D |
5,000 |
29,427 |
|
- |
|
| Lippman Marc E |
Director |
– • – |
2007-12-14 |
4 |
OE |
$0.10 |
$2,000 |
D/D |
20,000 |
77,500 |
|
- |
|
1805 Records found
|
|
Page 58 of 73 |
|
|
